Founded Date: 2020-01-01
Funding Status: Early Stage Venture
Total Funding: 32000000.0
Employee Number: 1-10
Headquarters: New York, New York, United States
Last Funding Date: 2022-07-28
Investors Number: 8.0
Last Funding Type: Series A
Estimated Revenue: $1M to $10M
Industry: Early Drug Development